Gliesse Pharmaceuticals Private limited

Facility 1

General, Cephalosporin's and Bectalactum Oral Solids, liquid and External Preparations facility accredited with WHO GMP, NDA UGANDA, PPB KENYA, NAFDAC NIGERIA, PMPB MALAWI, FDA GHANA, TFDA TANZANIA, FDA PHILIPPINES, NMRA SRILANKA, SBDMA YEMEN, FDA MYANMAR

Facility 2

Own Oral Solids facility open for all country Audits, currently accredited with WHO GMP Geneva, PERU DIGEMID, Philippines FDA, NPPB Kenya.

Facility 3

Liquid, Dry Powder and Lyophilized Injectables facility accredited with EU-GMP, TGA AUSTRALIA, COLOMBIA INVIMA, UKRAINE MOH, FMHACA ETHIOPIA, SRI LANKA NMRA, FDA PHILIPPINES, MOH SYRIA, PP KENYA, MOH CAMBODIA, DDA NEPAL and WHO GENEVA

Facility 4

Oral Solid and Injectable Oncology Facility accredited with EU GMP, UK MHRA, Ukraine PICS, South Korea PICS, ISP Chile, Philippines FDA, Russia Etc.

Facility 5

Biotech Facility with PFS, Dry Powder Injectables having triggered US FDA, EU-GMP and already accredited with WHO GENEVA, PICS, ANVISA, INVIMA COLOMBIA, NNHPD CANADA approvals